Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C
Hepatitis Research and Treatment · 2010
DOI: 10.1155/2010/702748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2010. Verfasst von Makoto Numata und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tokai University School of Medicine, Isehara 259-1193, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
To clarify the impact of adherence, we treated 122 genotype 1 high viral titer chronic hepatitis C patients with pegylated interferon (peg-IFN) and ribavirin for 48 weeks at nine referral hospitals, and evaluated the prognostic factors with a focus on the adherence to the treatment. This study included 68 (55.7%) treatment-naïve patients and 54 (44.3%) patients who did not respond to the previous treatment. Multivariate analysis revealed adherence to peg-IFN and ribavirin as the only significant predictor. Sustained virological response (SVR) rate was 72.2%, 19.0%, and 27.3% in patients given ≥80%, 60%–80%, and
Autor:innen und Institutionen
- Department of Gastroenterology, Tokai University School of Medicine, Isehara 259-1193, Japan.
Zitieren
APA
Numata, M., Kagawa, T., Kojima, S., Hirose, S., Nagata, N., Shiraishi, K., Watanabe, N., Shiozawa, H., Nishizaki, Y., Motegi, S., Takashimizu, S., Kamochi, J., Wasada, M., Ohno, T., Tei, Y., Nakano, A., Yamada, T., Atsukawa, K., Watanabe, T., & Mine, T. (2010). Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C. Hepatitis Research and Treatment. https://doi.org/10.1155/2010/702748
Vancouver
Numata M, Kagawa T, Kojima S, Hirose S, Nagata N, Shiraishi K, et al. Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C. Hepatitis Research and Treatment. 2010. doi:10.1155/2010/702748
BibTeX
@article{Numata2010,
author = {Numata, Makoto and Kagawa, Tatehiro and Kojima, Sei-Ichiro and Hirose, Shunji and Nagata, Naruhiko and Shiraishi, Koichi and Watanabe, Norihito and Shiozawa, Hirokazu and Nishizaki, Yasuhiro and Motegi, Shigeyuki and Takashimizu, Shinji and Kamochi, Jun-Ichiro and Wasada, Mitsuru and Ohno, Takashi and Tei, Yoshihiro and Nakano, Atsushi and Yamada, Takuji and Atsukawa, Kazuhiro and Watanabe, Tetsu and Mine, Tetsuya},
title = {Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C},
journal = {Hepatitis Research and Treatment},
year = {2010},
doi = {10.1155/2010/702748}
}
EUVIMED